Systematic analysis of the multiple bioactivities of green tea through a network pharmacology approach

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Zhang, Shoude ^a   Shan, Lei ^b   Li, Qiao ^a   Wang, Xia ^a   Li, Shiliang ^a   Zhang, Yuan ^a   Fu, Jianjun ^a   Liu, Xiaofeng ^a   Li, Honglin ^a   Zhang, Weidong ^a,b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPHENOL DERIVATIVE;

ALZHEIMER DISEASE; ANTICARDIOVASCULAR DISEASE MECHANISM; ANTIDIABETIC ACTIVITY; ANTIMUSCULAR DISEASE MECHANISM; ANTINEOPLASTIC ACTIVITY; ANTINEURODEGENERATIVE DISEASE MECHANISM; ARTICLE; CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG ACTIVITY; DRUG MECHANISM; DRUG TARGETING; HUMAN; INFLAMMATORY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MENTAL DISEASE; MUSCLE DISEASE; PLEIOTROPY; PROTEIN PROTEIN INTERACTION; TEA;

EID: 84918508066     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/512081     Document Type: Article

References (46)

1. H. Mukhtar and N. Ahmad, "Tea polyphenols: prevention of cancer and optimizing health," The American Journal of Clinical Nutrition, vol. 71, no. 6, supplement, pp. 1698S-1702S, 2000.
2. D. L. McKay and J. B. Blumberg, "The role of tea in human health: an update," Journal of the American College of Nutrition, vol. 21, no. 1, pp. 1-13, 2002.
3. F. L. Chung, J. Schwartz, C. R. Herzog, and Y. M. Yang, "Tea and cancer prevention: studies in animals and humans," Journal of Nutrition, vol. 133, no. 10, pp. 3268S-3274S, 2003.
4. M. Reto, M. E. Figueira, H. M. Filipe, and C. M. M. Almeida, "Chemical composition of green tea (Camellia sinensis) infusions commercialized in Portugal," Plant Foods for Human Nutrition, vol. 62, no. 4, pp. 139-144, 2007.
5. S. B. Wan, D. Chen, Q. P. Dou, and T. H. Chan, "Study of the green tea polyphenols catechin-3-gallate (CG) and epicatechin-3-gallate (ECG) as proteasome inhibitors," Bioorganic and Medicinal Chemistry, vol. 12, no. 13, pp. 3521-3527, 2004.
6. K. H. Miean and S. Mohamed, "Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants," Journal of Agricultural and Food Chemistry, vol. 49, no. 6, pp. 3106-3112, 2001.
7. M. Hämäläinen, R. Nieminen, P. Vuorela, M. Heinonen, and E. Moilanen, "Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages," Mediators of Inflammation, vol. 2007, Article ID 45673, 10 pages, 2007.
8. N. Khan, F. Afaq, M. Saleem, N. Ahmad, and H. Mukhtar, "Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate," Cancer Research, vol. 66, no. 5, pp. 2500-2505, 2006.
9. S. Li and B. Zhang, "Traditional Chinese medicine network pharmacology: theory, methodology and application," Chinese Journal of Natural Medicines, vol. 11, no. 2, pp. 110-120, 2013.
10. A. S. Azmi, "Network pharmacology for cancer drug discovery: are we there yet?" Future Medicinal Chemistry, vol. 4, no. 8, pp. 939-941, 2012.
11. J. von Eichborn, M. S. Murgueitio, M. Dunkel, S. Koerner, P. E. Bourne, and R. Preissner, "PROMISCUOUS: a database for network-based drug-repositioning," Nucleic Acids Research, vol. 39, no. 1, pp. D1060-D1066, 2011.
12. J. Gong, C. Cai, X. Liu et al., "ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method," Bioinformatics, vol. 29, no. 14, pp. 1827-1829, 2013.
13. G. A. Maggiora and M. A. Johnson, Concepts and Applications of Molecular Similarity, John Wiley & Sons, New York, NY, USA, 1990.
14. X. Liu, H. Jiang, and H. Li, "SHAFTS: a hybrid approach for 3D molecular similarity calculation. 1. method and assessment of virtual screening," Journal of Chemical Information and Modeling, vol. 51, no. 9, pp. 2372-2385, 2011.
15. W. Lu, X. Liu, X. Cao et al., "SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration," Journal of Medicinal Chemistry, vol. 54, no. 10, pp. 3564-3574, 2011.
16. X. Liu, S. Ouyang, B. Yu et al., "PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach," Nucleic Acids Research, vol. 38, no. 2, pp. W609-W614, 2010.
17. A. Franceschini, D. Szklarczyk, S. Frankild et al., "STRING v9.1: protein-protein interaction networks, with increased coverage and integration," Nucleic Acids Research, vol. 41, no. 1, pp. D808-D815, 2013.
18. K. Peng, W. Xu, J. Zheng et al., "The disease and gene annotations (DGA): anannotation resource for human disease," Nucleic Acids Research, vol. 41, no. 1, pp. D553-D560, 2013.
19. X. Liu, D. Y. Zhang, W. Zhang, X. Zhao, C. Yuan, and F. Ye, "The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma," Nutrition and Cancer, vol. 63, no. 3, pp. 466-475, 2011.
20. S. Shankar, S. Ganapathy, and R. K. Srivastava, "Green tea polyphenols: biology and therapeutic implications in cancer," Frontiers in Bioscience, vol. 12, no. 13, pp. 4881-4899, 2007.
21. N. Khan and H. Mukhtar, "Multitargeted therapy of cancer by green tea polyphenols," Cancer Letters, vol. 269, no. 2, pp. 269-280, 2008.
22. H. Luo, G. O. Rankin, N. Juliano, B.-H. Jiang, and Y. C. Chen, "Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFκB-cMyc-p21 pathway," Food Chemistry, vol. 130, no. 2, pp. 321-328, 2012.
23. P. Bulzomi, P. Galluzzo, A. Bolli, S. Leone, F. Acconcia, and M. Marino, "The pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals," Journal of Cellular Physiology, vol. 227, no. 5, pp. 1891-1898, 2012.
24. J. D. Lambert, J. Hong, G.-Y. Yang, J. Liao, and C. S. Yang, "Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations," The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 284S-291S, 2005.
25. F. Afaq, V. M. Adhami, N. Ahmad, and H. Mukhtar, "Inhibition of ultraviolet B-mediated activation of nuclear factor κB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate," Oncogene, vol. 22, no. 7, pp. 1035-1044, 2003.
26. Z. Dong, W. Y. Ma, C. Huang, and C. S. Yang, "Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins," Cancer Research, vol. 57, no. 19, pp. 4414-4419, 1997.
27. M. Shimizu, A. Deguchi, J. T. E. Lim, H. Moriwaki, L. Kopelovich, and I. B. Weinstein, "(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells," Clinical Cancer Research, vol. 11, no. 7, pp. 2735-2746, 2005.
28. V. M. Adhami, I. A. Siddiqui, N. Ahmad, S. Gupta, and H. Mukhtar, "Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer," Cancer Research, vol. 64, no. 23, pp. 8715-8722, 2004.
29. D. S. Wheeler, J. D. Catravas, K. Odoms, A. Denenberg, V. Malhotra, and H. R. Wong, "Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1β-dependent proinflammatory signal transduction in cultured respiratory epithelial cells," Journal of Nutrition, vol. 134, no. 5, pp. 1039-1044, 2004.
30. H. M. Kim and J. Kim, "The effects of green tea on obesity and type 2 diabetes," Diabetes and Metabolism Journal, vol. 37, no. 3, pp. 173-175, 2013.
31. H. Iso, C. Date, K. Wakai et al., "The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults," Annals of Internal Medicine, vol. 144, no. 8, pp. 554-562, 2006.
32. C.-H. Wu, F.-H. Lu, C.-S. Chang, T.-C. Chang, R.-H. Wang, and C.-J. Chang, "Relationship among habitual tea consumption, percent body fat, and body fat distribution," Obesity Research, vol. 11, no. 9, pp. 1088-1095, 2003.
33. O. H. Ryu, J. Lee, K. W. Lee et al., "Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients," Diabetes Research and Clinical Practice, vol. 71, no. 3, pp. 356-358, 2006.
34. F. Fiordaliso, A. Leri, D. Cesselli et al., "Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death," Diabetes, vol. 50, no. 10, pp. 2363-2375, 2001.
35. M. V. Blagosklonny, "TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists," Cell Death and Disease, vol. 4, no. 12, article e964, 2013.
36. S. Mandel, T. Amit, L. Reznichenko, O. Weinreb, and M. B. H. Youdim, "Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders," Molecular Nutrition and Food Research, vol. 50, no. 2, pp. 229-234, 2006.
37. S. Mandel, G. Maor, and M. B. Youdim, "Iron and α-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate," Journal of Molecular Neuroscience, vol. 24, no. 3, pp. 401-416, 2004.
38. K. Rezai-Zadeh, D. Shytle, N. Sun et al., "Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice," Journal of Neuroscience, vol. 25, no. 38, pp. 8807-8814, 2005.
39. C.-X. Gong, T. Lidsky, J. Wegiel, L. Zuck, I. Grundke-Iqbal, and K. Iqbal, "Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease," The Journal of Biological Chemistry, vol. 275, no. 8, pp. 5535-5544, 2000.
40. A. D. C. Alonso, T. Zaidi, I. Grundke-Iqbal, and K. Iqbal, "Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease," Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 12, pp. 5562-5566, 1994.
41. P. V. A. Babu and D. Liu, "Green tea catechins and cardiovascular health: an update," Current Medicinal Chemistry, vol. 15, no. 18, pp. 1840-1850, 2008.
42. T. M. Buetler, M. Renard, E. A. Offord, H. Schneider, and U. T. Ruegg, "Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species," The American Journal of Clinical Nutrition, vol. 75, no. 4, pp. 749-753, 2002.
43. B. J. Petrof, J. B. Shrager, H. H. Stedman, A. M. Kelly, and H. L. Sweeney, "Dystrophin protects the sarcolemma from stresses developed during muscle contraction," Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 8, pp. 3710-3714, 1993.
44. P. E. M. Smith, P. M. A. Calverley, R. H. T. Edwards, G. A. Evans, and E. J. Campbell, "Practical problems in the respiratory care of patients with muscular dystrophy," The New England Journal of Medicine, vol. 316, no. 19, pp. 1197-1205, 1987.
45. M.-H. Disatnik, J. Dhawan, Y. Yu et al., "Evidence of oxidative stress in mdx mouse muscle: studies of the pre- necrotic state," Journal of the Neurological Sciences, vol. 161, no. 1, pp. 77-84, 1998.
46. R. Singh, N. Akhtar, and T. M. Haqqi, "Green tea polyphenol epigallocatechi3-gallate: Inflammation and arthritis," Life Sciences, vol. 86, no. 25-26, pp. 907-918, 2010.